Zaeske Adam H. 4

What Happened Adam H. Zaeske, Chief Commercial Officer of Harmony Biosciences (HRMY), had 7,500 restricted stock units (RSUs) convert to common shares on April 7, 2026. Of those shares, 3,173 were withheld by the issuer to satisfy required income tax withholdings at $27.62 per share, a withholding value of approximately $87,638. The net number of new shares delivered to Zaeske from this vesting event was 4,327.

Key Details

• Transaction date: April 7, 2026; Form 4 filed April 9, 2026 (timely filing).
• Conversions: 7,500 RSUs converted to 7,500 shares (transaction code M).
• Tax withholding: 3,173 shares withheld (transaction code F) at $27.62/share = $87,638 withheld.
• Net shares received from this vesting: 4,327 (7,500 − 3,173).
• Shares owned following the transaction: not disclosed in the provided excerpt of the filing.
• Footnotes: F1 — shares were withheld to satisfy income tax withholding upon vesting. F2 — the RSUs vest in four equal annual installments beginning April 7, 2026, subject to continued service; each RSU converts to one share.

Context This filing reflects a routine vesting/settlement of RSUs and associated tax withholding by the issuer — not an open-market purchase or sale. The conversion of RSUs into shares (and withholding to cover taxes) is a common executive compensation event and does not, by itself, indicate a buying or selling decision in the market.